Remed Co.,Ltd. (KOSDAQ:302550)
South Korea · Delayed Price · Currency is KRW 3,115.00
-25.00 (-0.80%)
At close: Mar 27, 2026
Remed Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 24,505 | 25,554 | 18,536 | 21,363 | 20,195 |
Other Revenue | - | -0 | - | - | -0 |
| 24,505 | 25,554 | 18,536 | 21,363 | 20,195 | |
Revenue Growth (YoY) | -4.11% | 37.86% | -13.23% | 5.79% | 21.41% |
Cost of Revenue | 10,542 | 11,508 | 9,589 | 10,293 | 9,880 |
Gross Profit | 13,963 | 14,046 | 8,947 | 11,071 | 10,315 |
Selling, General & Admin | 8,773 | 8,422 | 7,949 | 6,593 | 5,711 |
Research & Development | 3,286 | 3,483 | 2,940 | 2,426 | 2,731 |
Amortization of Goodwill & Intangibles | 86.32 | 97.71 | 98.73 | 90.89 | 71.99 |
Other Operating Expenses | 56.75 | 93.38 | 97.1 | 88.47 | 53.18 |
Operating Expenses | 13,237 | 12,925 | 11,807 | 9,410 | 9,192 |
Operating Income | 725.84 | 1,121 | -2,860 | 1,661 | 1,123 |
Interest Expense | -876.57 | -1,174 | -1,244 | -966.8 | -775.51 |
Interest & Investment Income | 283.1 | 444.54 | 847.53 | 687.73 | 706.26 |
Earnings From Equity Investments | - | -105.74 | -150.16 | -111.99 | -100.22 |
Currency Exchange Gain (Loss) | -116.8 | 668.74 | 334.91 | 272.88 | 542.56 |
Other Non Operating Income (Expenses) | -125.82 | 3,304 | -283.26 | 3,424 | -576.44 |
EBT Excluding Unusual Items | -110.25 | 4,259 | -3,355 | 4,967 | 919.81 |
Impairment of Goodwill | - | -268.88 | - | - | - |
Gain (Loss) on Sale of Investments | -57.18 | -343.93 | 342.47 | -336.6 | - |
Gain (Loss) on Sale of Assets | -97.8 | 4,400 | -0.01 | -70.63 | -36.72 |
Other Unusual Items | -34.13 | - | 3,992 | - | - |
Pretax Income | -299.35 | 8,045 | 979.66 | 4,560 | 883.08 |
Income Tax Expense | -263.88 | 664.59 | 660.41 | 608.71 | 130.75 |
Earnings From Continuing Operations | -35.47 | 7,381 | 319.24 | 3,951 | 752.33 |
Minority Interest in Earnings | 561.66 | -208.68 | 477.92 | 48.88 | - |
Net Income | 526.2 | 7,172 | 797.17 | 4,000 | 752.33 |
Net Income to Common | 526.2 | 7,172 | 797.17 | 4,000 | 752.33 |
Net Income Growth | -92.66% | 799.69% | -80.07% | 431.70% | - |
Shares Outstanding (Basic) | 31 | 31 | 31 | 31 | 31 |
Shares Outstanding (Diluted) | 58 | 32 | 31 | 31 | 31 |
Shares Change (YoY) | 81.79% | 4.97% | - | 0.35% | 1.84% |
EPS (Basic) | 17.00 | 234.00 | 26.02 | 130.56 | 24.64 |
EPS (Diluted) | 9.00 | 223.00 | 26.00 | 130.56 | 24.60 |
EPS Growth | -95.96% | 757.69% | -80.09% | 430.73% | - |
Free Cash Flow | 1,530 | 658.57 | 2,708 | 261.1 | -7,431 |
Free Cash Flow Per Share | 26.16 | 20.48 | 88.39 | 8.52 | -243.41 |
Gross Margin | 56.98% | 54.97% | 48.27% | 51.82% | 51.08% |
Operating Margin | 2.96% | 4.39% | -15.43% | 7.78% | 5.56% |
Profit Margin | 2.15% | 28.07% | 4.30% | 18.72% | 3.72% |
Free Cash Flow Margin | 6.24% | 2.58% | 14.61% | 1.22% | -36.80% |
EBITDA | 2,142 | 2,399 | -1,905 | 2,417 | 1,684 |
EBITDA Margin | 8.74% | 9.39% | -10.28% | 11.31% | 8.34% |
D&A For EBITDA | 1,417 | 1,278 | 954.51 | 755.6 | 560.7 |
EBIT | 725.84 | 1,121 | -2,860 | 1,661 | 1,123 |
EBIT Margin | 2.96% | 4.39% | -15.43% | 7.78% | 5.56% |
Effective Tax Rate | - | 8.26% | 67.41% | 13.35% | 14.81% |
Advertising Expenses | 861.37 | 535.11 | 725.79 | 420.15 | 299.26 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.